NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)

CompletedNA

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Conditions: Adult Hospitalized

Interventions: nasopharyngeal sample

Countries: France

This study assesses the seasonal of influenza vaccine effectiveness in adults hospitalised with laboratory-confirmed influenza through a network of hospitals in France

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age ≥ 18 year
* Affiliated with social security health insurance
* Written informed consent
* Patients hospitalized for 24 hours and presenting an influenza-like illness in the last 7 days before the hospitalization

Exclusion Criteria:

* Against indication for influenza vaccination(Hypersensitivity to the active substances, to any of the excipients and to trace eg eggs, including ovalbumin, chicken protein)
* Patients institutionalized without regular community interaction
* Patient already hospitalized for respiratory infection during the 2012-2013 influenza season
* Flu already virologically documented in the current influenza season 2012-2013 (RT-PCR, multiple RT-PCR and / or culture.)

Locations (1)

Paris, France